NASDAQ:MNPR | News — Page 2 | Monopar Therapeutics

MNPR News — Page 2

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2020-11-12Current reportSEC filingMonopar Therapeutics filed Form 8-KMonopar Therapeutics filed Form 8-K covering items 2.02.
2020-11-09Current reportSEC filingMonopar Therapeutics filed Form 8-KMonopar Therapeutics filed Form 8-K covering items 7.01,9.01.
2020-09-09Current reportSEC filingMonopar Therapeutics filed Form 8-KMonopar Therapeutics filed Form 8-K covering items 7.01,9.01.
2020-08-19Current reportSEC filingMonopar Therapeutics filed Form 8-KMonopar Therapeutics filed Form 8-K covering items 7.01,9.01.
2020-08-12Current reportSEC filingMonopar Therapeutics filed Form 8-KMonopar Therapeutics filed Form 8-K covering items 7.01,9.01.
2020-08-10Current reportSEC filingMonopar Therapeutics filed Form 8-KMonopar Therapeutics filed Form 8-K covering items 7.01,8.01,9.01.
2020-08-06Current reportSEC filingMonopar Therapeutics filed Form 8-KMonopar Therapeutics filed Form 8-K covering items 2.02,9.01.
2020-06-30Current reportSEC filingMonopar Therapeutics filed Form 8-KMonopar Therapeutics filed Form 8-K covering items 7.01,9.01.
2020-06-16Current reportSEC filingMonopar Therapeutics filed Form 8-KMonopar Therapeutics filed Form 8-K covering items 7.01,8.01,9.01.
2020-06-15Current reportSEC filingMonopar Therapeutics filed Form 8-KMonopar Therapeutics filed Form 8-K covering items 5.02,5.07.
2020-05-07Current reportSEC filingMonopar Therapeutics filed Form 8-KMonopar Therapeutics filed Form 8-K covering items 2.02.
2020-03-27Current reportSEC filingMonopar Therapeutics filed Form 8-KMonopar Therapeutics filed Form 8-K covering items 2.02.
2020-02-18Current reportSEC filingMonopar Therapeutics filed Form 8-KMonopar Therapeutics filed Form 8-K covering items 7.01,9.01.
2020-01-13Current reportSEC filingMonopar Therapeutics filed Form 8-KMonopar Therapeutics filed Form 8-K covering items 1.01.
2020-01-07Current reportSEC filingMonopar Therapeutics filed Form 8-KMonopar Therapeutics filed Form 8-K covering items 5.05.
2019-06-27Current reportSEC filingMonopar Therapeutics filed Form 8-KMonopar Therapeutics filed Form 8-K covering items 5.07.
2018-07-02Current reportSEC filingMonopar Therapeutics filed Form 8-KMonopar Therapeutics filed Form 8-K covering items 5.02.
2018-06-05Current reportSEC filingMonopar Therapeutics filed Form 8-KMonopar Therapeutics filed Form 8-K covering items 5.07.